These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1742755)

  • 21. Acute fatal myeloencephalopathy after combined intrathecal chemotherapy in a child with acute lymphoblastic leukemia.
    von der Weid NX; de Crousaz H; Beck D; Deonna T; Miklossy J; Janzer RC
    Med Pediatr Oncol; 1991; 19(3):192-8. PubMed ID: 2023567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of accidental intrathecal methotrexate overdose with intrathecal carboxypeptidase G2.
    Widemann BC; Balis FM; Shalabi A; Boron M; O'Brien M; Cole DE; Jayaprakash N; Ivy P; Castle V; Muraszko K; Moertel CL; Trueworthy R; Hermann RC; Moussa A; Hinton S; Reaman G; Poplack D; Adamson PC
    J Natl Cancer Inst; 2004 Oct; 96(20):1557-9. PubMed ID: 15494606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accidental intrathecal vincristine administration. Report of a case.
    Manelis J; Freudlich E; Ezekiel E; Doron J
    J Neurol; 1982; 228(3):209-13. PubMed ID: 6186795
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of inadvertent intrathecal injection of vincristine.
    Dyke RW
    N Engl J Med; 1989 Nov; 321(18):1270-1. PubMed ID: 2797094
    [No Abstract]   [Full Text] [Related]  

  • 25. Severe neurotoxicities in a case of Charcot-Marie-Tooth disease type 2 caused by vincristine for acute lymphoblastic leukemia.
    Nishikawa T; Kawakami K; Kumamoto T; Tonooka S; Abe A; Hayasaka K; Okamoto Y; Kawano Y
    J Pediatr Hematol Oncol; 2008 Jul; 30(7):519-21. PubMed ID: 18797198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Encephalopathy is the dose-limiting toxicity of intravenous hepsulfam: results of a phase I trial in patients with advanced hematological malignancies.
    Larson RA; Geller RB; Janisch L; Milton J; Grochow LB; Ratain MJ
    Cancer Chemother Pharmacol; 1995; 36(3):204-10. PubMed ID: 7781139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized trial of induction therapy (daunorubicin, vincristine, prednisone versus daunorubicin, vincristine, prednisone, cytarabine and 6-thioguanine) in adult acute lymphoblastic leukemia with long-term follow-up: an Eastern Cooperative Oncology Group Study (E3486).
    Wiernik PH; Cassileth PA; Leong T; Hoagland HC; Bennett JM; Paietta E; Oken MM;
    Leuk Lymphoma; 2003 Sep; 44(9):1515-21. PubMed ID: 14565653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inappropiate ADH secretion associated with massive vincristine overdosage.
    Wakem CJ; Bennett JM
    Aust N Z J Med; 1975 Jun; 5(3):266-9. PubMed ID: 169781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of acute lymphoblastic leukaemia (ALL).
    Jacobs P; Wood L
    Eur J Haematol; 1992 Aug; 49(2):53-8. PubMed ID: 1397240
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved survival for children with B-cell acute lymphoblastic leukemia and stage IV small noncleaved-cell lymphoma: a pediatric oncology group study.
    Bowman WP; Shuster JJ; Cook B; Griffin T; Behm F; Pullen J; Link M; Head D; Carroll A; Berard C; Murphy S
    J Clin Oncol; 1996 Apr; 14(4):1252-61. PubMed ID: 8648381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progressive paresthesia and weakness after intrathecal chemotherapy.
    Marshall R; Gupta ND; Palacios E; Neitzschman HR
    J La State Med Soc; 2008; 160(2):92-4. PubMed ID: 18681351
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medical misadventure = human tragedy.
    Turner P; Thornton N
    Axone; 2001 Jun; 22(4):30-5. PubMed ID: 14621503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurophysiological findings in long-term survivors of acute lymphoblastic leukaemia in childhood treated with the BFM protocol 81 SR-A/B.
    Ueberall MA; Skirl G; Strassburg HM; Wenzel D; Hertzberg H; Langer T; Meier W; Berger-Jones K; Huk WJ; Korinthenberg R; Beck JD
    Eur J Pediatr; 1997 Sep; 156(9):727-33. PubMed ID: 9296540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inadvertent intrathecal administration of intravenous vincristine.
    Seger AC
    J Pediatr Hematol Oncol; 2010 Mar; 32(2):167. PubMed ID: 20147847
    [No Abstract]   [Full Text] [Related]  

  • 35. [Unintentional intrathecal administration of a tenfold dose of methotrexate].
    Kaczmarek M; Radwańska U
    Acta Haematol Pol; 1990; 21(2):228-30. PubMed ID: 2131723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased-risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: results of the European Organization for Research and Treatment of Cancer 58881 randomized phase III trial.
    Millot F; Suciu S; Philippe N; Benoit Y; Mazingue F; Uyttebroeck A; Lutz P; Mechinaud F; Robert A; Boutard P; Marguerite G; Ferster A; Plouvier E; Rialland X; Behard C; Plantaz D; Dresse MF; Philippet P; Norton L; Thyss A; Dastugue N; Waterkeyn C; Vilmer E; Otten J;
    J Clin Oncol; 2001 Apr; 19(7):1935-42. PubMed ID: 11283125
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inadvertent intrathecal administration of vincristine: has anything changed?
    Gilbar P
    J Oncol Pharm Pract; 2012 Mar; 18(1):155-7. PubMed ID: 21965437
    [No Abstract]   [Full Text] [Related]  

  • 38. Simple method to eliminate the risk of inadvertent intrathecal vincristine administration.
    Stefanou A; Dooley M
    J Clin Oncol; 2003 May; 21(10):2044; author reply 244. PubMed ID: 12743160
    [No Abstract]   [Full Text] [Related]  

  • 39. Acute ascending motoric paraplegia following intrathecal chemotherapy for treatment of acute lymphoblastic leukemia in children: case reports and review of the literature.
    Rolf N; Boehm H; Kaindl AM; Lauterbach I; Suttorp M
    Klin Padiatr; 2006; 218(6):350-4. PubMed ID: 17080338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
    Lee EJ; Petroni GR; Schiffer CA; Freter CE; Johnson JL; Barcos M; Frizzera G; Bloomfield CD; Peterson BA
    J Clin Oncol; 2001 Oct; 19(20):4014-22. PubMed ID: 11600602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.